| Identification | Back Directory | [Name]
CC-671 | [CAS]
1618658-88-0 | [Synonyms]
CC-671
CS-2792
CC-671
(CC671
Inhibitor,inhibit,Cyclin dependent kinase,CC671,CC-671,CC 671,CDK
4-(4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-3-methoxy-N-methylbenzamide | [Molecular Formula]
C28H28N6O4 | [MDL Number]
MFCD31619262 | [MOL File]
1618658-88-0.mol | [Molecular Weight]
512.56 |
| Chemical Properties | Back Directory | [density ]
1.351±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO:60.0(Max Conc. mg/mL);117.06(Max Conc. mM) | [form ]
A crystalline solid | [pka]
12.12±0.50(Predicted) | [color ]
Off-white to light green |
| Hazard Information | Back Directory | [Uses]
CC-671, is a novel dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) inhibitor for the treatment of triple negative breast cancer initiated from a phenotypic screen. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
Cckinase, Inc.
|
| Tel: |
+1 (732)236-3202 |
| Website: |
www.cckinase.com |
|